Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

mounts due from related parties

-

99 

 Inventories

1,259

2,065 

 Prepayments and other current assets

4,779

4,567 

 Deferred tax assets

315

- 

Total current assets73,10969,382Non-current assets: 

 Derivative assets

261

- 

 Property, plant, equipment and software, net

60,147

70,450 

 Land use right, net

4,221

7,352 

 Other long-term assets

204

791 

Total non-current assets64,83378,593 

Total assets137,942147,975LIABILITIESCurrent liabilities: 

 Short-term bank borrowings

755

773 

 Accounts payable

10,549

11,664 

 Amounts due to related parties

1,025

1,502 

 Salary and welfare payable

4,040

2,774 

 Income tax payable

1,910

931 

 Advance from customers

1,650

1,012 

 Other payables and accruals

4,477

5,055 

 Deferred tax liabilities

-

335 

Total current liabilities24,40624,046 

Total liabilities24,40624,046Commitments and contingenciesEQUITY 

Ordinary shares (US$0.001 par value; 429,999,350 shares authorized;
335,600,000 shares issued and outstanding as of December 31, 2010
and June 30, 2011, respectively)

336

336 

Additional paid in capital

78,989

81,403 

Statutory reserves

6,795

6,795 

Retained earnings

23,655

30,019 

Accumulated other comprehensive income

3,761

5,376 

Total equity113,536123,929 <
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held ... drugs to treat neurodegenerative diseases such as amyotrophic ... G. Miller , M.D., Director of the Forbes Norris ... Medical Center in San Francisco, has been awarded a ... to help fund a Phase 2 clinical study ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today ... Convention in Philadelphia, PA. , The presentation took place on Tuesday, June ... plans for the development of APX3330 for the treatment of pancreatic cancer. A ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) ... of Resverlogix have approved the resolutions relating to: ... of 5,600,000 units at a price of $2.67 ... being comprised of one common share and 0.075358 ... approximately CAD$15 million; and (ii) the amendment to ...
(Date:6/30/2015)... San Francisco, CA (PRWEB) , ... June 30, ... ... in FMT Patients , Study will provide new insights on mechanics of fecal ... announced a new partnership to study the microbiome of patients undergoing fecal microbiota ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... venture capital firm, hopes to make waves in ... technology companies. Also, state Assembly Republicans moved to ... studies that require destroying embryos, and the state ... Original air date: Saturday, April 16, 2005 ...
... featured speaker at the Digital Healthcare Conference 2005 ... decade, technology applied to medical records and other information has ... to more common usage. At the Marshfield Clinic , ... hands by the time medical informatics associations and journals began ...
... comes to flexible work practices women are the proverbial canaries ... many corporate career tracks is any indication, the air must ... " On Ramps and Off Ramps: Keeping Talented Women on ... The Center for Work-Life Policy and Carolyn Buck Luce of ...
Cached Biology Technology:Carl Christensen says Marshfield Clinic's history gives it an IT edge 2Carl Christensen says Marshfield Clinic's history gives it an IT edge 3Carl Christensen says Marshfield Clinic's history gives it an IT edge 4Are women opting out or shut out from career tracks? 2Are women opting out or shut out from career tracks? 3Are women opting out or shut out from career tracks? 4
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
(Date:6/23/2015)... 2015   Valencell, a leader in ... a recent study that illustrates its PerformTek biometric ... activity. In a study conducted at Valencell,s Biometric ... the Apple Watch against a chest strap – ... activity. The study demonstrated that Valencell,s biometric technology ...
(Date:6/18/2015)... 18, 2015 This report analyzes the worldwide ... following Product Segments, which includes Immunoassay Analyzers and Reagents: ... Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report ... Canada , Japan , ... Latin America , and Rest of ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29
... indirectly via the release of melatonin, which implicates ... and the fasting glucose level. The finding could ... far beyond the primarily symptomatic therapy approaches to ... Diabetes mellitus and diabetes-associated late complications are among ...
... Wis. Jan. 12, 2009 The 2009 winners ... are Prasad Adusumilli, M.D. and Lee Goodglick, Ph.D. The ... pleural invasion and the role of estrogen in lung ... surgeon specializing in lung cancer at Memorial Sloan-Kettering Cancer ...
... Research published today reveals the major influence of fish on ... the health of coral reefs and other marine life. ... UK, US and Canada, could help solve a mystery that ... 2009) in Science , the study provides new insights ...
Cached Biology News:Is there a relationship between sleep-wake rhythm and diabetes? 2National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients 2Fish guts explain marine carbon cycle mystery 2Fish guts explain marine carbon cycle mystery 3
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. It can incubate up to ...
... nucleotide structure called a ?cap? is ... naturally-occurring eukaryotic mRNAs and many viral ... a portion of the GTP present ... results in the synthesis of transcripts ...
... A modified nucleotide structure called ... 5?-end of most naturally-occurring eukaryotic mRNAs ... Cap Analog for a portion of ... vitro transcription reaction results in the ...
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
Biology Products: